Fig. 1From: Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational studyCumulative proportion of patients breathing without assistance in the two neuromuscular blocker agents (NMBA) groups using Kaplan-Meir curves. Comparison with log rank testBack to article page